Natus Medical Incorporated Jonathan A. KennedyExecutive Vice President and Chief Financial Officer (925) 223-6700 InvestorRelations@Natus.com
Natus Medical (BABY) beat analysts' estimates for earnings and revenue for the 2016 third quarter and issued upbeat guidance for the fourth quarter and full year.
Natus Medical (BABY) cut its fiscal 2016 third-quarter revenue outlook due to a shortfall from halted production in its Seattle facility.
Trade-Ideas LLC identified Natus Medical (BABY) as a "dead cat bounce" (down big yesterday but up big today) candidate
Natus Medical (BABY) stock is dipping late Monday afternoon after the company announced preliminary revenue for the 2016 first quarter, which missed analysts’ expectations.